HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dong Zhen Selected Research

pteryxin

3/2022Protective effect of pteryxin on LPS-induced acute lung injury via modulating MAPK/NF-κB pathway and NLRP3 inflammasome activation.
2/2022Pteryxin attenuates LPS-induced inflammatory responses and inhibits NLRP3 inflammasome activation in RAW264.7 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dong Zhen Research Topics

Disease

4Neoplasms (Cancer)
01/2022 - 08/2018
3Acute Lung Injury
10/2022 - 03/2022
3Cardiomegaly (Heart Hypertrophy)
06/2022 - 10/2021
3Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 10/2021
2Heart Failure
06/2022 - 10/2021
2Fibrosis (Cirrhosis)
06/2022 - 10/2021
2Inflammation (Inflammations)
02/2022 - 01/2021
2Breast Neoplasms (Breast Cancer)
01/2021 - 01/2020
1Cardiotoxicity
04/2022
1Bronchitis
03/2022
1Lung Injury
03/2022
1Metabolic Diseases (Metabolic Disease)
01/2022
1Triple Negative Breast Neoplasms
01/2022
1Atherosclerotic Plaque (Atheroma)
01/2021

Drug/Important Bio-Agent (IBA)

3Ethanol (Ethyl Alcohol)IBA
10/2022 - 04/2022
3Isoproterenol (Isoprenaline)FDA LinkGeneric
06/2022 - 10/2021
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2022 - 01/2022
2pteryxinIBA
03/2022 - 02/2022
2Therapeutic UsesIBA
03/2022 - 01/2022
2Circular RNAIBA
01/2022 - 01/2021
2EucalyptolIBA
01/2022 - 10/2021
2Long Noncoding RNAIBA
01/2021 - 01/2020
1Interleukin-17 (Interleukin 17)IBA
09/2022
1peiminineIBA
09/2022
1forsythiasideIBA
09/2022
1Proteins (Proteins, Gene)FDA Link
09/2022
1CytokinesIBA
09/2022
1verticineIBA
09/2022
1Eosine Yellowish-(YS) (Eosin)IBA
06/2022
1Hematoxylin (Haematoxylon)IBA
06/2022
1InflammasomesIBA
03/2022
1Expectorants (Mucolytics)IBA
03/2022
1AntipyreticsIBA
03/2022
1Antitussive Agents (Antitussives)FDA Link
03/2022
1Drug CombinationsIBA
01/2022
1MelatoninIBA
01/2022
1AntioxidantsIBA
01/2022
1caryophylleneIBA
01/2022
1linaloolIBA
01/2022
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2022
1Competitive Endogenous RNAIBA
01/2022
1Monoterpenes (Monoterpenoids)IBA
10/2021
1Factor V (Coagulation Factor V)IBA
01/2021
1CollagenIBA
01/2021
1LipidsIBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1Polysaccharides (Glycans)IBA
08/2018

Therapy/Procedure

1Combination Drug Therapy (Combination Chemotherapy)
01/2022
1Therapeutics
01/2022
1Subcutaneous Injections
10/2021
1Heterologous Transplantation (Xenotransplantation)
01/2020